Ryan Chizner, DO, MPH, FACC, RPVI
ryanchizner.bsky.social
Ryan Chizner, DO, MPH, FACC, RPVI
@ryanchizner.bsky.social
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
🚨 #AI-based #ECG analysis significantly improved #STEMI detection, ⬇️ false
activations and enhanced recognition of non-conventional presentations, based on late-breaking science from #TCT2025 and published in #JACCINT.

Read more: https://bit.ly/3LdZn6b #CardioSky #MedSky @jaccjournals.bsky.social
October 28, 2025 at 10:07 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Despite Class I guideline indications, most patients with severe aortic regurgitation remain untreated. This #JACC review outlines advances in diagnosis, surgical refinements, and emerging transcatheter options to bridge this gap. https://bit.ly/3WPcVHM

#TCT2025 #vhdAR #CardioSky
October 28, 2025 at 2:05 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Expand your #InterventionalCardiology knowledge with SCAI ebooks—comprehensive, peer-reviewed resources covering the latest procedures, techniques, and best practices.

Download these tools for FREE➡️ https://scai.org/publications/ebooks

#SCAIMCSebook #SCAITTEERebook #CardioSky
October 28, 2025 at 12:01 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
The October QITip is here! Learn a step-by-step approach for managing entrapped gear during #PCI with insights on pulling/telescoping, trapping, snaring, and bailout strategies.

Read the full tip ➡️ https://ow.ly/O9lf50Xgwez

#CardioSky #QualityImprovement
October 24, 2025 at 12:02 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
In STEMI patients with multivessel disease, reduced LVEF increases ischaemic risk — but the COMPLETE trial showed complete revascularisation reduces major CV events regardless of LVEF. #cardiosky #medsky #LVEF #cardiology
eurointervention.pcronline.com/article/impa...
October 24, 2025 at 10:17 AM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis
Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis
Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis ccox@crf.org Fri, 10/24/2025 - 16:03 Yael L. Maxwell More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.
www.tctmd.com
October 24, 2025 at 8:12 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
🔍 Large-bore vascular closure: ProGlide or MANTA?
A new patient-level meta-analysis of randomized trials compares outcomes between these two commonly used devices.
Discover the results here 👇👇
eurointervention.pcronline.com/article/sutu...
#cardiosky #medsky #vascularclosure
October 25, 2025 at 8:35 AM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
According to the phase 3 HYPERION trial conducted by Vallerie V. McLaughlin, MD, FACC, et al., adding sotatercept to standard care lowers the risk of clinical worsening in patients recently diagnosed with #cvPAH.

📰 Read the full article: https://bit.ly/4q2pE7w
#CardioSky
HYPERION: Sotatercept Delays Worsening of PAH Diagnosed Within First Year - American College of Cardiology
bit.ly
October 8, 2025 at 9:59 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
🔴 High BP affects ~50% of U.S. adults.

🆕 2025 ACC/AHA Guideline reaffirms <130/80 mm Hg goal & updates risk tools, prevention & resistant HTN care.

Summary in #CardiologyMaghttps://bit.ly/4q2GBP5

#Hypertension #ClinicalGuidelines #CardioSky
October 8, 2025 at 6:10 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
When compared with SAPT, #DAPT after valve-in-valve #TAVI to treat surgical bioprosthesis dysfunction may be associated with a lower 1-year #stroke incidence, according to a study published in #JACCINT. 📖 Read more: https://bit.ly/4o5Q8De
October 6, 2025 at 9:30 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Subclinical primary aldosteronism is an under-recognized driver of cardiovascular risk. Could it be a new target for CV prevention? Read our Circulation editorial —>
September 29, 2025 at 7:03 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Early and accurate diagnosis of coronary artery disease is critical for improved patient outcomes. @asnc.bsky.social, @eanm.org, ACNM, and SNMMI have developed new guidelines for 18F-flurpiridaz PET myocardial perfusion imaging (MPI) and blood flow quantitation.

snmmi.org/Web/News/Art...
New International Guideline Provides Expert Guidance for PET Imaging of Patients with Coronary Arter
The Society of Nuclear Medicine and Molecular Imaging (SNMMI), American Society of Nuclear Cardiology (ASNC), European Association of Nuclear Medicine (EANM), and American College of Nuclear Medicine ...
snmmi.org
September 19, 2025 at 1:18 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Transthyretin cardiac amyloidosis is the leading cause of HF in older Black patients, particularly for men, and screening with nuclear imaging should be more frequent for this population, based on findings from the SCAN-MP study. www.tctmd.com/news/transth...
Transthyretin Cardiac Amyloidosis a Common Cause of HF in Older Black Patients
With effective therapies available, the findings suggest screening with nuclear imaging should be more frequent in this population.
www.tctmd.com
September 21, 2025 at 12:58 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Have you read our newest #ASEGuideline, "Guidelines for the Standardization of Adult Echocardiography Reporting?"

This report focuses on the final phases of the diagnostic imaging process, specifically reporting and communicating exam results. Read it now: bit.ly/46wUcFD
September 22, 2025 at 9:00 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Great article for residents. LGE establishes the basis for re-entry for V-Tach. #CardioSky
#SCD

academic.oup.com/eurheartj/ar...
Late gadolinium enhancement imaging and sudden cardiac death
Abstract. The prediction and management of sudden cardiac death risk continue to pose significant challenges in cardiovascular care despite advances in the
academic.oup.com
September 22, 2025 at 10:49 AM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
A 🆕 ECDP addressing "10 issues for the clinician in TR evaluation & management" focuses specifically on patients w/ secondary #vhdTR in the chronic setting & is intended to serve as a bridge to a future update of ACC/AHA #cvVHD guideline.

Read more: https://bit.ly/4ncVbSp

#JACC #CardioSky #MedSky
September 23, 2025 at 8:15 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
High LDL cholesterol often has no symptoms but can have serious consequences.

Amgen’s documentary, “The Making of a Heart Attack,” shares real stories of people affected & what they wish they'd known.

📺 AttackHeartDisease.com/Documentary

#CholesterolMonth #CardioSky #AmgenSponsored
September 8, 2025 at 12:09 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Valvular heart disease from tricuspid regurgitation has 5 grades of severity. This JAMA Insights discusses the classification, diagnosis, management, and treatment options for tricuspid regurgitation. ja.ma/3HLkw6A
August 28, 2025 at 4:00 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Decongestion Secrets ("ammo" for rounds):

In a multi-center study of 283 acute heart failure patients, changes in renal filtration markers (cystatin C or creatinine) with aggressive diuresis were not associated with changes in markers of renal tubular injury (NAG, NGAL, or KIM-1)
August 27, 2025 at 12:53 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
#AI-based stethoscopes can accurately diagnose left-sided valvular heart disease, according to original research published in #JACCAdvances.

Get details ➡️ https://bit.ly/3HRzFTI #cvVHD #CardioSky #MedSky @jaccjournals.bsky.social
August 25, 2025 at 7:15 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Early detection = better prevention. 🫀
Identifying & managing high-risk patients is key to stopping CVD before it starts.

👉 www.sciencedirect.com/science/arti...

#HeartHealth #CardioPrevention #CardioSky #MedSky
August 22, 2025 at 3:19 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Ten-Year Follow Up Data of the Edwards SAPIEN XT TAVI prosthesis.

Guideline changing?

www.accessdata.fda.gov/scripts/cdrh...

#CardioSky #MedSky
August 23, 2025 at 6:49 AM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
If you’re in CV training navigating an unexpected financial hardship, the ACC Benevolence Fund is here for you. This confidential 🤝 program is designed to help our members during tough times—because community care matters.

Learn more & apply by Aug. 30: https://bit.ly/4oUb6q4 #CardioSky #MedSky
August 24, 2025 at 7:55 PM
Reposted by Ryan Chizner, DO, MPH, FACC, RPVI
Periodically I repost this very useful document (glossary of terms) for those try to master lipids/lipoproteins. Print it out - peterattiamd.com/glossary-lip... @nationallipid.bsky.social @aspcardio.bsky.social @familyheartfdn.bsky.social @escardio.bsky.social
Narrative glossary: lipids - Peter Attia
A companion post for the podcast episodes with Thomas Dayspring, M.D., FACP, FNLA (October 15-19, 2018).
peterattiamd.com
August 23, 2025 at 1:03 PM